<b>Industry Reports</b><br> &#183 CROs Hand Poor Grades to Sponsors<br> &#183 A Bitter Pill for SMOs<br> &#183 Month in Review<br> <b>CentreStage Europe</b><br> &#183 Early Signs of a Market Shifting Toward For-Profit European Clinical Investigators<br> <b>Grant Opportunities</b><br> &#183 Eye on Colorectal Cancer<br> &#183 Colorectal Cancer Pipeline<br> &#183 Trial Watch<br> &#183 Opportunities Underway<br> <b>Publisher's Letter</b>